Biotech

All Articles

Lilly- backed weight loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has submitte...

Aelis' marijuana usage medication flunks phase 2b, driving Indivior to reconsider $100M choice

.Aelis Farma's hopes of getting a fast, positive choice on a $100 thousand choice settlement have ac...

ProKidney standstills period 3 test not needed for tissue therapy approval

.ProKidney has actually stopped some of a set of phase 3 trials for its own cell therapy for renal i...

Vaxcyte surges on 'stunning' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what experts called "impressive" stage 1/2 records for its 31-valent pneumococcal ...

Recursion's brain health condition trial presents scant evidence of efficiency

.Recursion has discovered by means of an early examination of its own tech-enabled approach to medic...

Acepodia, Pfizer click all together for chemistry-based tissue therapy

.Call it a case of really good chemical make up: Acepodia, a biotech based upon Nobel Champion scien...

Praxis epilepsy medicine decreases confiscations in phase 2 hearing

.Practice Accuracy Medicines has actually racked up another midphase succeed in epilepsy this year, ...

Three officers surrender as Dyne blog posts blended records for DMD applicant

.After getting away from a clinical hold a number of years back, Dyne Rehab has exposed brand new pe...

Arrowhead fires off period 3 information in uncommon metabolic disease in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own hand in advance of a prospective face-off with Ionis...

Pfizer, Valneva present lyme ailment try efficient for second booster

.Pfizer as well as Valneva might possess about 2 even more years to stand by prior to they make the ...